XXXX -receptor gene expression in @entity2 .

@entity6181 @entity1 @entity146 @entity5 @entity14243 @entity2 @entity1149 @entity3
OBJECTIVE: @entity14243 ( @entity14243 ) stimulates cell motility via binding its receptor ( @entity6181 ) and @entity6181 is engaged in @entity5 cell motility and the @entity6181 gene expression level may define a more @entity146 phenotype. In this study, we investigated the expression of @entity6181 in @entity2 cells and revealed its roles in the cell motility of a @entity5 . We detected @entity6181 expression in tissue specimens from @entity1 with @entity1149 ( @entity1149 ) and assessed their clinical characteristics. METHODS: Using reverse transcription-polymerase chain reaction (RT-PCR) analyses and phagokinetic assay, we studied the correlation between the level of @entity6181 gene expression and cell motility. We quantified the expression of @entity6181 in 51 @entity1 with @entity1149 to investigate the relationship between @entity6181 expression and clinicopathologic factors and prognosis. RESULTS: We found that @entity2 cell lines with higher @entity6181 gene expression tended to have larger cell motility than those with lower @entity6181 gene expression. The @entity6181 gene expression was significantly associated with lymph node @entity3 , and stage. The overall survival rate for @entity1 with a high level of @entity6181 gene expression with @entity5 was significantly worse than for those individuals whose @entity5 had low @entity6181 expression. Furthermore, @entity6181 expression was significantly related to survival by multivariate analysis. CONCLUSION: These data indicate that @entity14243 -R may contribute to @entity5 progression and @entity6181 gene expression can serve as a useful prognostic marker in @entity1149 .
